piracetam has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, AS | 1 |
Elgharabawy, RM | 1 |
Al-Najjar, AH | 1 |
Pandey, S | 1 |
Garabadu, D | 1 |
Baratsevich, ER | 1 |
Posokhina, OV | 1 |
3 other studies available for piracetam and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Diabetes Mellitus, Type 2; Female; Humans; M | 2017 |
Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats.
Topics: Amnesia; Animals; Blood Glucose; Brain Diseases; Brain-Derived Neurotrophic Factor; Choline; Diabete | 2017 |
[Approaches to the therapy of neurological presentations in diabetes mellitus].
Topics: Adult; Aged; Antioxidants; Cognition Disorders; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | 2010 |